AbstractBackground and objectiveThe number of infused CD34+cells (CD34+i) has been associated with absolute lymphocyte count (ALC) and the outcome undergoing autologous hematopoietic stem cell transplantation (HSCT) in patients with hematologic malignancies. The study's aim was to analyze the relationship between CD34+i, ALC and prognosis in this patients.Patients and methodMedical records of 163 patients receiving HSCT between 2005 and 2012 were reviewed.ResultsWe found significant and inversely proportional relationship between the CD34+i and the days required to reach ALC≥500/μl according to the regression line: days=−0.981×number of CD34+i+18.09.ConclusionsWe have obtained a predictive model of lymphocyte recovery based recovery of CD34...
AbstractThe CD34+ cell surface antigen is expressed on progenitor cells required for blood stem cell...
OBJECTIVE: The aim of this study was to evaluate which CD34(+) cell subset contained in leukapheresi...
AbstractSeveral studies have shown that a higher lymphocyte count 3-4 weeks after allogeneic stem ce...
Autologous hematopoietic stem cell transplantation (ASCT) is an established treatment for patients w...
AbstractAllogeneic stem cell transplantation (ASCT) has improved the outcome of acute myelogenous le...
Allogeneic stem cell transplantation (ASCT) has improved the outcome of acute myelogenous leukemia (...
We conducted a retrospective study to evaluate the clinical impact of an early recovery of posttrans...
The aim of this study was to evaluate which CD34(+) cell subset contained in leukapheresis products ...
A retrospective, observational study was performed of 112 patients who underwent autologous haematop...
Autologous stem cell transplantation (ASCT) is the standard of care for patients with multiple myelo...
AbstractAutologous stem cell transplantation (ASCT) is the standard of care for patients with multip...
AbstractWe studied platelet engraftment in 58 patients with acute myeloid leukemia in first remissio...
Background: We analyzed the hematopoietic reconstitution and outcome of 508 patients with multiple ...
Background/Aim. Autologous stem cell transplants (ASCTs) improve the rate of overall survival (OS) i...
The stem cell source for autologous transplantation has shifted from bone marrow to peripheral blood...
AbstractThe CD34+ cell surface antigen is expressed on progenitor cells required for blood stem cell...
OBJECTIVE: The aim of this study was to evaluate which CD34(+) cell subset contained in leukapheresi...
AbstractSeveral studies have shown that a higher lymphocyte count 3-4 weeks after allogeneic stem ce...
Autologous hematopoietic stem cell transplantation (ASCT) is an established treatment for patients w...
AbstractAllogeneic stem cell transplantation (ASCT) has improved the outcome of acute myelogenous le...
Allogeneic stem cell transplantation (ASCT) has improved the outcome of acute myelogenous leukemia (...
We conducted a retrospective study to evaluate the clinical impact of an early recovery of posttrans...
The aim of this study was to evaluate which CD34(+) cell subset contained in leukapheresis products ...
A retrospective, observational study was performed of 112 patients who underwent autologous haematop...
Autologous stem cell transplantation (ASCT) is the standard of care for patients with multiple myelo...
AbstractAutologous stem cell transplantation (ASCT) is the standard of care for patients with multip...
AbstractWe studied platelet engraftment in 58 patients with acute myeloid leukemia in first remissio...
Background: We analyzed the hematopoietic reconstitution and outcome of 508 patients with multiple ...
Background/Aim. Autologous stem cell transplants (ASCTs) improve the rate of overall survival (OS) i...
The stem cell source for autologous transplantation has shifted from bone marrow to peripheral blood...
AbstractThe CD34+ cell surface antigen is expressed on progenitor cells required for blood stem cell...
OBJECTIVE: The aim of this study was to evaluate which CD34(+) cell subset contained in leukapheresi...
AbstractSeveral studies have shown that a higher lymphocyte count 3-4 weeks after allogeneic stem ce...